CABIO(SH:688089) Tong Hua Shun Cai Bao·2025-03-27 10:35Financial Performance - The company reported a basic earnings per share of 0.7400 yuan for 2024, an increase of 37.04% compared to 0.5400 yuan in 2023 [1] - The net profit for 2024 was 1.24 billion yuan, reflecting a growth of 36.26% from 0.91 billion yuan in 2023 [1] - Operating revenue reached 5.56 billion yuan, up 25.23% from 4.44 billion yuan in the previous year [1] - The return on equity (ROE) improved to 8.16%, a 29.94% increase from 6.28% in 2023 [1] Shareholder Structure - The top ten unrestricted shareholders collectively hold 92.049 million shares, accounting for 54.71% of the circulating shares, with a change of 1.1306 million shares from the previous period [1] - Wuhan Xiwang Biological Engineering Co., Ltd. remains the largest shareholder with 7,434,000 shares, representing 44.17% of the total share capital [2] - New entrants among the top shareholders include the China Agricultural Bank - Huaxia Stable Growth Mixed Securities Investment Fund, holding 194.77 thousand shares, and Du Bin with 97.64 thousand shares [2] Dividend Distribution - The company announced a dividend distribution plan of 2 yuan per share (including tax) [4]